Search

Your search keyword '"van Vugt JP"' showing total 36 results

Search Constraints

Start Over You searched for: Author "van Vugt JP" Remove constraint Author: "van Vugt JP"
36 results on '"van Vugt JP"'

Search Results

1. Suicidal ideation in a European Huntington's disease population

2. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

3. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

4. Observing Huntington's Disease: the European Huntington's Disease Network's REGISTRY

5. Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease

6. β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease

7. Discrepancies in reporting the CAG repeat lengths for Huntington's disease

9. Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease.

10. Feasibility of external rhythmic cueing with the Google Glass for improving gait in people with Parkinson's disease.

11. Asymmetries in reactive and anticipatory balance control are of similar magnitude in Parkinson's disease patients.

12. Parkinson's disease patients compensate for balance control asymmetry.

13. Event-related mu-rhythm desynchronization during movement observation is impaired in Parkinson's disease.

14. Balance asymmetry in Parkinson's disease and its contribution to freezing of gait.

15. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.

16. Toward automated, at-home assessment of mobility among patients with Parkinson disease, using a body-worn accelerometer.

17. Ambulatory monitoring of activities and motor symptoms in Parkinson's disease.

18. Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's disease.

19. Discontinuation of ropinirole and pramipexole in patients with Parkinson's disease: clinical practice versus clinical trials.

20. Intracranial hypertension in 2 children with marfan syndrome.

21. Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease.

22. Pharmacogenetics of antiparkinsonian drug treatment: a systematic review.

23. Detecting asymmetries in balance control with system identification: first experimental results from Parkinson patients.

24. Hypernatremia from a hunger strike as a cause of osmotic myelinolysis.

25. Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.

26. Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study.

27. Impaired antagonist inhibition may contribute to akinesia and bradykinesia in Huntington's disease.

28. Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease.

29. A convenient method to reduce crosstalk in surface EMG. Cobb Award-winning article, 2001.

30. Postural instability and falls in Parkinson's disease.

31. Unified Huntington's disease rating scale: a follow up.

32. Habituation of lower leg stretch responses in Parkinson's disease.

33. Clozapine versus placebo in Huntington's disease: a double blind randomised comparative study.

34. A shortened version of the motor section of the Unified Huntington's Disease Rating Scale.

35. Hypokinesia in Huntington's disease.

36. Long latency postural reflexes are under supraspinal dopaminergic control.

Catalog

Books, media, physical & digital resources